EXCLUSIVE I watched diabetes kill three siblings so know the signs you've hit the point of no return... it's coming for the rest of us
But one day at work, the type 2 diabetic and eldest sister among eight siblings, said she felt unwell and stepped out to rest in her car. An hour later, she was found slumped over the steering wheel, unresponsive.
Your browser does not support iframes.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Times
5 hours ago
- Times
‘Functional beverages' are booming — but is it all hype?
Before you take that magnesium supplement or sit down to meditate, what if a drink could help you relax? Enter 'functional beverages', drinks that claim to possess additional health benefits beyond those of a standard fizzy drink or fruit juice. Functional drinks are surging in popularity, with supermarkets in Britain seeing sales increase by 24.5 per cent in the past year, according to Worldpanel by Numerator. The market research firm also said that almost 30 per cent of UK households now purchase functional drinks. However, Nichola Ludlam-Raine, a dietician with more than 15 years of clinical experience in the NHS, has warned that she 'wouldn't rely on them [functional drinks] for measurable health benefits'. Ludlam-Raine, who now works privately and is the author of How Not to Eat Ultra-Processed , said: 'Functional drinks containing ingredients like CBD [cannabidiol], lion's mane [a type of mushroom], and ashwagandha [a herb typically used in ayurvedic medicine] are part of a growing wellness trend, but the science isn't as strong as the marketing.'
Daily Mail
6 hours ago
- Daily Mail
NFL star heading to Philadelphia Eagles in bombshell trade after overcoming leukemia battle
The Philadelphia Eagles are acquiring wide receiver John Metchie III from the Houston Texans, according to multiple reports. Metchie, a four-year veteran of the league, will be playing in only his third year of action after sitting out his rookie season. After being selected in the second round of the 2022 NFL Draft, Metchie was diagnosed with acute promyelocytic leukemia. He missed the entire campaign as he underwent treatment.
Times
7 hours ago
- Times
Obese to get soups and shakes diet instead of weight-loss jabs
Low-calorie soups and shakes are to be prescribed to thousands of overweight people in Scotland in an attempt to reduce their dependence on expensive weight-loss drugs and provide longer-lasting health benefits. From January, 3,000 patients who have been newly diagnosed with type 2 diabetes will be recruited for a clinical trial. About 300,000 Scots live with type 2 diabetes, a condition commonly linked to obesity, in which badly regulated blood sugar levels can increase the risk of heart disease, kidney disease, strokes or nerve conditions. About 10,000 of them are being treated with weight-loss drugs such as Ozempic, Wegovy and Mounjaro, with injections costing the NHS £3,000 a year. The estimated annual bill of £30 million is expected to rise as manufacturers raise prices. NHS chiefs believe that not only will the soups and shakes plan be less expensive, it will also bring longer-term health benefits. In the Total Diet Replacement (TDR) plan, to be rolled out over three years, patients who have recently been diagnosed with type 2 diabetes and are deemed eligible will be given low-calorie substitutes for their breakfast, lunch and dinner. The replacement meals, containing a maximum of 900 calories a day, will be delivered to patients for between three and five months. • What to do now Mounjaro's hiking its prices, by an obesity expert After this initial period, normal food will be reintroduced, but with guidance given on healthy meals through online consultations and an app. The ambition is for patients to lose up to 10 per cent of their body weight over a year. Doctors are also optimistic that up to 40 per cent of the trial participants will achieve remission from type 2 diabetes within a year. There are fears that the weight lost through injections — which work by suppressing the appetite — may last only as long as the patient is taking the drug. By contrast, the effects of diet changes should prove more long-lasting and cost effective, NHS officials believe. The TDR scheme is set to cost £5.6 million for 3,000 patients, a one-off cost of about £1,866 per person. Doctors hope the plan will help patients to fundamentally alter their diet and lifestyle. A spokesman for the Scottish government said: 'We anticipate that around 35 to 40 per cent will achieve remission from type 2 diabetes at the end of their first year on the programme, with a majority of patients benefiting from a clinically significant average weight loss of 10 per cent.' This would lead to reductions in blood pressure and contribute to a reduced risk of cardiovascular disease. He added: 'We will measure impact by the number of patients recruited into this programme, the number who achieve remission and the number with clinically significant weight loss.'
